採用
Company Overview:
Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is leveraging its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated, one-time, potentially curative genetic therapies. Designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications, Prime Editors have the potential to repair almost all types of genetic mutations and work in many different tissues, organs and cell types.
Prime Medicine is currently progressing a diversified portfolio of investigational therapeutic programs organized around our core areas of focus: hematology, immunology & oncology, liver and lung. Across each core area, Prime Medicine is focused initially on a set of high value programs, each targeting a disease with well-understood biology and a clearly defined clinical development and regulatory path, and each expected to provide the foundation for expansion into additional opportunities. For more information, please visit www.primemedicine.com.
Co-Op Assignment Overview:
Prime Medicine is seeking a co-op for the Fall 2026 semester with experience in molecular/cell biology-related wet-lab work to join the Prime Editing Platform team. The candidate will contribute to the development of RNA innovations that advance Prime Medicine’s platform capabilities. The qualified candidate will work with a highly collaborative, fast-paced team to design, screen, optimize and validate Prime Editor mRNAs in relevant cell models to support and expand mRNA-based screening efforts. In parallel, the candidate will help drive the exploration and development of RNA modalities across the organization. The candidate will receive consistent mentorship from experienced scientists and learn a variety of different lab-based techniques and skills. Furthermore, the co-op will learn about data analysis and will have an opportunity to present his/her/their work in team meetings. In this position, the candidate will develop a deep understanding of RNA technologies and gene editing and how these efforts fit into the overall drug discovery process.
Primary Responsibilities:
· Conduct mRNA production via in-vitro transcription (IVT) and purification.
· Maintain mammalian cell culture, perform cell passaging.
· Transfect mammalian cells with Prime Editing reagents to determine gene editing activity.
· Execute and develop routine cell-based assays to screen for novel mRNA constructs.
· Perform analytical procedures including ELISA, luciferase assay, qRT-PCR assay and gDNA.
· Maintain a timely and well-organized electronic lab notebook (ELN).
· Provide preliminary data analysis, interpretation, and contribute to presentations within Platform team and cross functional teams.
Required Qualifications:
· B.S. /M.S. candidate in in Cell & Molecular Biology, Chemical Biology, Biochemistry, or related majors.
· Firm understanding of, molecular biology, cell biology, and biochemistry. Background understanding of genome editing is a plus.
· Previous wet-lab (molecular/cell biology) experience.
· Excellent troubleshooting and communication skills.
· Interested in solving complex problems in a cross functional collaborative environment.
Preferred Qualifications:
· Familiar with cell-based assays, mammalian cell culture and transfection, and nucleic acid biochemistry.
· Excels at some of the following lab techniques: PCR, nucleotide extraction, molecular cloning, ELISA, etc.
· Ability to use Word, Excel, PowerPoint, and Graph Pad Prism for data documentation, analysis, and presentation.
· Experience with computational molecular biology tools (e.g., DNA visualization software)
The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, skills, and education.
U.S. Pay Range
$23—$33 USD
Prime Medicine is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, age, sexual orientation, gender identity, disability, veteran status, or any other classification protected by law.
総閲覧数
1
応募クリック数
0
模擬応募者数
0
スクラップ
0
類似の求人

Associate Commerce Director, GQ
Condé Nast · 1 World Trade Center, New York, NY

Software Engineer - Internal Platform
Baseten · San Francisco

Part-Time Store Merchandising Associate
Kohl's · Macomb (0007)

Part Time (30 Hours) Associate Banker, Irving Blvd Branch, Irving, TX Bilingual Spanish Required
JPMorgan Chase · Irving, TX, United States, US

Housekeeper
UTA · Los Angeles Office
Prime Medicineについて

Prime Medicine
Series BBiotechnology company.
51-200
従業員数
Cambridge
本社所在地
レビュー
3.9
10件のレビュー
ワークライフバランス
3.8
報酬
3.2
企業文化
4.3
キャリア
3.5
経営陣
2.4
72%
友人に勧める
良い点
Supportive and collaborative team
Flexible work arrangements and good work-life balance
Interesting and challenging projects
改善点
Poor management communication and organization
Limited career advancement opportunities
High workload and occasional long hours
給与レンジ
17件のデータ
Director
Director · DIR. OF BUSINESS DEVLP, HEAD OF ALLIANCES & CORP. INITIATIVE
2件のレポート
$273,000
年収総額
基本給
$210,000
ストック
-
ボーナス
-
$273,000
$273,000
面接体験
62件の面接
難易度
3.7
/ 5
期間
14-28週間
内定率
30%
体験
ポジティブ 69%
普通 21%
ネガティブ 10%
面接プロセス
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
よくある質問
Tell me about a challenging project
System design question
Coding problem
Why this company
ニュース&話題
Prime Medicine (PRME) awards CFO 800,000 stock options at $3.67 - Stock Titan
Stock Titan
News
·
3d ago
Prime Medicine (PRME) CFO Makhni Svetlana Ni submits initial Form 3 - Stock Titan
Stock Titan
News
·
3d ago
Prime Medicine slides after pricing $125.4M stock offering - MSN
MSN
News
·
4d ago
Prime Medicine names Svetlana Makhni as chief financial officer - Investing.com
Investing.com
News
·
4d ago